Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

News
Bupropion and Contingency Management Combination Could Help Curb Cocaine Use Among OUD Patients
03/21/2023
Pairing contingency management and bupropion, an antidepressant medication that is also used for smoking cessation, could be a treatment option for curbing cocaine use by patients who are in treatment for opioid use disorder, according to...
Pairing contingency management and bupropion, an antidepressant medication that is also used for smoking cessation, could be a treatment option for curbing cocaine use by patients who are in treatment for opioid use disorder, according to...
Pairing contingency management...
03/21/2023
Addiction Professional
News
Skin Disease Medication Also Effective in Alcohol Use Disorder Treatment
02/28/2023
A pill used to treat a common skin disease was found to reduce alcohol consumption by more than half among patients diagnosed with alcohol use disorder, according to findings published recently by researchers at Oregon Health & Science...
A pill used to treat a common skin disease was found to reduce alcohol consumption by more than half among patients diagnosed with alcohol use disorder, according to findings published recently by researchers at Oregon Health & Science...
A pill used to treat a common...
02/28/2023
Addiction Professional
News
Loosening MAT Prescribing Rules Did Not Increase Proportion of Overdose Deaths Involving Buprenorphine
01/24/2023
The proportion of opioid overdose deaths involving the medication buprenorphine did not increase in the months after prescribing flexibilities were enacted as a result of the COVID-19 pandemic, according to new research from NIDA and the CDC.
The proportion of opioid overdose deaths involving the medication buprenorphine did not increase in the months after prescribing flexibilities were enacted as a result of the COVID-19 pandemic, according to new research from NIDA and the CDC.
The proportion of opioid...
01/24/2023
Addiction Professional
News
MAT for OUD Initiated by Pharmacists Increases Patient Engagement in Pilot
01/13/2023
Pharmacists can safely and effectively start patients with opioid use disorder (OUD) on buprenorphine, according to a new pilot study from researchers at Brown University, Rhode Island Hospital, and the University of Rhode Island.
Pharmacists can safely and effectively start patients with opioid use disorder (OUD) on buprenorphine, according to a new pilot study from researchers at Brown University, Rhode Island Hospital, and the University of Rhode Island.
Pharmacists can safely and...
01/13/2023
Addiction Professional
News
SAMHSA Proposes Federal Rule Changes to Expand Access to OUD Treatment
12/14/2022
The Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), announced it is proposing to expand access to treatment for opioid use disorder (OUD) by updating federal...
The Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), announced it is proposing to expand access to treatment for opioid use disorder (OUD) by updating federal...
The Department of Health and...
12/14/2022
Addiction Professional
News
Buprenorphine During Pregnancy Associated With Less Neonatal Risk Than Methadone
12/06/2022
Pregnant women with opioid use disorder may have more favorable neonatal health outcomes with buprenorphine compared with methadone treatment, according to a study in the New England Journal of Medicine.
Pregnant women with opioid use disorder may have more favorable neonatal health outcomes with buprenorphine compared with methadone treatment, according to a study in the New England Journal of Medicine.
Pregnant women with opioid use...
12/06/2022
Addiction Professional
News
Fentanyl Vaccine Delivers Promising Results in Trial
11/17/2022
Researchers from the University of Houston have developed a fentanyl vaccine that could block the synthetic opioid’s ability to enter the brain, thus eliminating the “high” it produces—a potential game-changing development in the opioid...
Researchers from the University of Houston have developed a fentanyl vaccine that could block the synthetic opioid’s ability to enter the brain, thus eliminating the “high” it produces—a potential game-changing development in the opioid...
Researchers from the University...
11/17/2022
Addiction Professional
News
Naloxone Access Disparity Plaguing Rural Areas
11/01/2022
A lack of availability of the overdose-reversal medication naloxone has led to an increase in deaths in rural areas, according to a recent study by researchers from Penn State University.
A lack of availability of the overdose-reversal medication naloxone has led to an increase in deaths in rural areas, according to a recent study by researchers from Penn State University.
A lack of availability of the...
11/01/2022
Addiction Professional
News
Treatment Retention Improves for OUD Patients Who Engage in 2 Outpatient Visits in First Month
10/28/2022
Individuals with opioid use disorder (OUD) who engage in multiple outpatient visits within their first month of treatment are far more likely to remain engaged in treatment after 6 months, according to a new study.
Individuals with opioid use disorder (OUD) who engage in multiple outpatient visits within their first month of treatment are far more likely to remain engaged in treatment after 6 months, according to a new study.
Individuals with opioid use...
10/28/2022
Addiction Professional
News
Pew Panel Outlines OUD Metrics That States Should Be Tracking
10/24/2022
Pew Charitable Trusts has published an issue brief outlining action items for states to develop a core set of metrics to track relevant data and take stock of addiction treatment within their borders.
Pew Charitable Trusts has published an issue brief outlining action items for states to develop a core set of metrics to track relevant data and take stock of addiction treatment within their borders.
Pew Charitable Trusts has...
10/24/2022
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement